Schedule 13D ownership disclosure

IN8BIO INC

Common Stock, par value $0.0001 per share · CUSIP: 45674E109

Event date: 2025-12-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOS Fund II, LPReported CIK 0001714576

    Shares: 19,147.00 · Class: 0.2%

  • BIOS Fund II QP, LPReported CIK 0001716869

    Shares: 62,554.00 · Class: 0.6%

  • BIOS Fund II NT, LPReported CIK 0001728851

    Shares: 8,373.00 · Class: 0.1%

  • BIOS Incysus Co-Invest I, LPReported CIK 0001740029

    Shares: 33,247.00 · Class: 0.3%

  • BIOS Fund III, LPReported CIK 0001791917

    Shares: 19,024.00 · Class: 0.2%

  • BIOS Fund III QP, LPReported CIK 0001791916

    Shares: 124,253.00 · Class: 1.3%

  • BIOS Fund III NT, LPReported CIK 0001791910

    Shares: 20,066.00 · Class: 0.2%

  • Bios Clinical Opportunity Fund, LPReported CIK 0001988639

    Shares: 104,693.00 · Class: 1.1%

  • BP Directors, LPReported CIK 0001813311

    Shares: 0.00 · Class: 0.0%

  • Bios Equity Partners, LPReported CIK 0001813314

    Shares: 0.00 · Class: 0.0%

  • Bios Equity Partners II, LPReported CIK 0001813313

    Shares: 123,321.00 · Class: 1.3%

  • BIOS Equity Partners III, LPReported CIK 0001831976

    Shares: 163,343.00 · Class: 1.7%

  • Bios Equity COF, LPReported CIK 0002000747

    Shares: 104,693.00 · Class: 1.1%

  • Cavu Management, LPReported CIK 0001813270

    Shares: 286,664.00 · Class: 2.9%

  • BIOS Capital Management, LPReported CIK 0001813845

    Shares: 391,357.00 · Class: 4.0%

  • Cavu Advisors, LLCReported CIK 0001813310

    Shares: 286,664.00 · Class: 2.9%

  • BIOS Advisors GP, LLCReported CIK 0001813844

    Shares: 391,357.00 · Class: 4.0%

  • Kreis Leslie W.Reported CIK 0001813316

    Shares: 286,664.00 · Class: 2.9%

  • Fletcher Aaron G.L.Reported CIK 0001789490

    Shares: 391,357.00 · Class: 4.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001714576-25-000003
Form type
SCHEDULE 13D/A
Filer
BIOS Fund II, LP
CIK
CIK 1714576
Filed
Dec 29, 2025
Reporting period
Dec 22, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub